Walleye Trading
PTCT icon

Walleye Trading’s PTC Therapeutics PTCT Stock Holding History

Walleye Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,900
Closed -$296K – 4583
2025
Q4 		$296K Buy
3,900
+1,700
+77% +$124K ﹤0.01% 3164
2025
Q3 		$135K Buy
+2,200
New +$115K ﹤0.01% 3572
2023
Q2 		– Sell
-3,700
Closed -$179K – 5103
2023
Q1 		$179K Buy
+3,700
New +$169K ﹤0.01% 3580
2021
Q4 		– Sell
-21,900
Closed -$815K – 5760
2021
Q3 		$815K Buy
21,900
+4,200
+24% +$173K ﹤0.01% 2435
2021
Q2 		$748K Buy
17,700
+9,500
+116% +$407K ﹤0.01% 2458
2021
Q1 		$388K Sell
8,200
-8,700
-51% -$517K ﹤0.01% 2960
2020
Q4 		$1.03M Buy
+16,900
New +$996K ﹤0.01% 1946
2020
Q3 		– Sell
-13,600
Closed -$690K – 4508
2020
Q2 		$690K Buy
13,600
+1,100
+9% +$54K ﹤0.01% 1988
2020
Q1 		$558K Buy
12,500
+5,000
+67% +$252K ﹤0.01% 1791
2019
Q4 		$360K Buy
7,500
+1,200
+19% +$51K ﹤0.01% 2683
2019
Q3 		$213K Sell
6,300
-5,500
-47% -$239K ﹤0.01% 2880
2019
Q2 		$531K Buy
11,800
+7,700
+188% +$304K ﹤0.01% 2145
2019
Q1 		$154K Sell
4,100
-4,200
-51% -$141K ﹤0.01% 3217
2018
Q4 		$285K Buy
+8,300
New +$298K ﹤0.01% 3031

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Walleye Trading's PTCT Position: Q1 2026 in Review

Walleye Trading sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 15,926 shares — an estimated $1.21M sold.

Walleye Trading first reported a position in PTCT in Q1 2015 and held it in 11 quarters. The position peaked at $1.21M in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Walleye Trading reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 15,926 PTC Therapeutics shares in Q1 2026, an estimated $1.21M.
  • Walleye Trading first reported a position in PTC Therapeutics in Q1 2015 and held it in 11 quarters.
  • Walleye Trading's PTC Therapeutics position peaked at $1.21M in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.